rs759217526

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PVS1_ModerateBS1_SupportingBS2

The NM_018062.4(FANCL):​c.1096_1099dupATTA​(p.Thr367AsnfsTer13) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00365 in 1,612,828 control chromosomes in the GnomAD database, including 21 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T367T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0030 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 18 hom. )

Consequence

FANCL
NM_018062.4 frameshift

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:12B:5

Conservation

PhyloP100: 2.00

Publications

38 publications found
Variant links:
Genes affected
FANCL (HGNC:20748): (FA complementation group L) This gene encodes a ubiquitin ligase that is a member of the Fanconi anemia complementation group (FANC). Members of this group are related by their assembly into a common nuclear protein complex rather than by sequence similarity. This gene encodes the protein for complementation group L that mediates monoubiquitination of FANCD2 as well as FANCI. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2018]
VRK2 (HGNC:12719): (VRK serine/threonine kinase 2) This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. The encoded protein acts as an effector of signaling pathways that regulate apoptosis and tumor cell growth. Variants in this gene have been associated with schizophrenia. Alternative splicing results in multiple transcript variants that differ in their subcellular localization and biological activity. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0257 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00299 (455/152068) while in subpopulation NFE AF = 0.00422 (287/67940). AF 95% confidence interval is 0.00382. There are 3 homozygotes in GnomAd4. There are 204 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018062.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCL
NM_018062.4
MANE Select
c.1096_1099dupATTAp.Thr367AsnfsTer13
frameshift
Exon 14 of 14NP_060532.2
VRK2
NM_006296.7
MANE Select
c.*102_*105dupAATT
3_prime_UTR
Exon 13 of 13NP_006287.2Q86Y07-1
FANCL
NM_001410792.1
c.1156_1159dupATTAp.Thr387AsnfsTer13
frameshift
Exon 15 of 15NP_001397721.1A0A8Q3SIK5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCL
ENST00000233741.9
TSL:1 MANE Select
c.1096_1099dupATTAp.Thr367AsnfsTer13
frameshift
Exon 14 of 14ENSP00000233741.5Q9NW38-1
FANCL
ENST00000403295.8
TSL:1
c.1012_1015dupATTAp.Thr339AsnfsTer13
frameshift
Exon 13 of 13ENSP00000386097.3B5MC31
FANCL
ENST00000449070.6
TSL:1
c.919_922dupATTAp.Thr308AsnfsTer13
frameshift
Exon 11 of 11ENSP00000401280.2C9JZA9

Frequencies

GnomAD3 genomes
AF:
0.00299
AC:
455
AN:
151950
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000556
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00387
Gnomad ASJ
AF:
0.0118
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00265
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00422
Gnomad OTH
AF:
0.00622
GnomAD2 exomes
AF:
0.00301
AC:
750
AN:
249062
AF XY:
0.00308
show subpopulations
Gnomad AFR exome
AF:
0.000766
Gnomad AMR exome
AF:
0.00535
Gnomad ASJ exome
AF:
0.00669
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00181
Gnomad NFE exome
AF:
0.00350
Gnomad OTH exome
AF:
0.00497
GnomAD4 exome
AF:
0.00372
AC:
5434
AN:
1460760
Hom.:
18
Cov.:
31
AF XY:
0.00372
AC XY:
2702
AN XY:
726652
show subpopulations
African (AFR)
AF:
0.000508
AC:
17
AN:
33446
American (AMR)
AF:
0.00466
AC:
208
AN:
44654
Ashkenazi Jewish (ASJ)
AF:
0.00789
AC:
206
AN:
26104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39638
South Asian (SAS)
AF:
0.000708
AC:
61
AN:
86164
European-Finnish (FIN)
AF:
0.00179
AC:
95
AN:
53116
Middle Eastern (MID)
AF:
0.00209
AC:
12
AN:
5748
European-Non Finnish (NFE)
AF:
0.00414
AC:
4605
AN:
1111540
Other (OTH)
AF:
0.00381
AC:
230
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
287
573
860
1146
1433
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00299
AC:
455
AN:
152068
Hom.:
3
Cov.:
32
AF XY:
0.00274
AC XY:
204
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.000554
AC:
23
AN:
41526
American (AMR)
AF:
0.00387
AC:
59
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.0118
AC:
41
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4818
European-Finnish (FIN)
AF:
0.00265
AC:
28
AN:
10572
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00422
AC:
287
AN:
67940
Other (OTH)
AF:
0.00616
AC:
13
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00406
Hom.:
0
Bravo
AF:
0.00318
EpiCase
AF:
0.00415
EpiControl
AF:
0.00427

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
6
1
not provided (8)
2
3
-
Fanconi anemia complementation group L (5)
-
1
2
Fanconi anemia (3)
-
1
1
not specified (2)
-
1
-
FANCL-related disorder (1)
-
-
1
Hereditary cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.0
Mutation Taster
=182/18
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759217526; hg19: chr2-58386928; COSMIC: COSV52072800; COSMIC: COSV52072800; API